The global superbug crisis, threatening to kill 10 million annually by 2050, has found a potential adversary in phage therapy. This innovative treatment uses bacteriophages, viruses that attack bacteria, offering new hope against antibiotic-resistant infections. Clinical trials and research are underway to harness phages' potential, with promising results in treating severe infections and combating the spread of drug-resistant bacteria.